Inventor · disambiguated record
Jie Shen
Also filed as: SHEN JIE
6 granted patents·5 pending applications·4 citations·filing 2014–2023
71Inventor score
Files withWUHAN HUMANWELL INNOVATIVE DRUG RES AND DEVELOPMENT CENTER LIMITED COMPANY4ALLERGAN INC3HUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC3KUNMING CO YUNNAN TOBACCO CO1
Top patents by PatentIndex Score
11 records- 0174US10662174B2BTK inhibitorHUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC·Filed 2017·Granted May 26, 2020·1 cites·8 claims
- 0269US10428073B2Salt type and crystal type of 4H-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereofHUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC·Filed 2016·Granted Oct 1, 2019·1 cites·13 claims
- 0369US9266869B2Substituted dialkyl(oxido)-lambda4-sulfanylidene nicotinamide derivatives as kinase inhibitorsALLERGAN INC·Filed 2014·Granted Feb 23, 2016·1 cites·18 claims
- 0468US12221449B2Pyrrolopyrimidine derivative and use thereofWUHAN HUMANWELL INNOVATIVE DRUG RES AND DEVELOPMENT CENTER LIMITED COMPANY·Filed 2020·Granted Feb 11, 2025·1 cites·13 claims
- 0566US10941150B2Salt type and crystal type of 4h-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereofHUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC·Filed 2019·Granted Mar 9, 2021·0 cites·12 claims
- 0662US2024130362A1Composite solution for enhancing induced disease resistance of lentinan (lnt) to plant, preparation method of composite solution, and method for enhancing induced disease resistance of lnt to plantKUNMING CO YUNNAN TOBACCO CO·Filed 2023·Application pending·0 cites
- 0754US2015166518A1Substituted nicotinamide derivatives as kinase inhibitorsALLERGAN INC·Filed 2014·Application pending·0 cites
- 0848US2022056014A1Phenylpyrrolidine compound and use thereofWUHAN HUMANWELL INNOVATIVE DRUG RES AND DEVELOPMENT CENTER LIMITED COMPANY·Filed 2019·Application pending·0 cites
- 0947US9567324B2Substituted nicotinamide derivatives as kinase inhibitorsALLERGAN INC·Filed 2016·Granted Feb 14, 2017·0 cites·17 claims
- 1046US2022204479A1Pyrimidine compound and preparation method thereforWUHAN HUMANWELL INNOVATIVE DRUG RES AND DEVELOPMENT CENTER LIMITED COMPANY·Filed 2022·Application pending·0 cites
- 1145US2023125494A1Synthesis of novel ep4 antagonist and use in cancer and inflammationWUHAN HUMANWELL INNOVATIVE DRUG RES AND DEVELOPMENT CENTER LIMITED COMPANY·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jie Shen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →